M&A Update – Oct 8
– PCRX to be acquired by VTRS for $36.50 cash per share, 44.8% premium, $1.65 billion
– ATKR shareholders approved PRY merger, closing Oct 19
– CCO / Mubadala Capital / TWG Global cleared CFIUS, closing Oct 14
– CSR / IRT filed DEFM14a, votes Nov 10, closing Q4 2026
– ATH.to / CVE.to set Nov 27 vote
– ACVA / CPRT extended tender offer to Oct 15


